Cvs Pharmacy #10332 Durable Medical Equipment & Medical Supplies Location: 3148 W 3500 S, West Valley City, Utah 84119 Phone: (801) 963-2389 |
Cvs Pharmacy #10424 Durable Medical Equipment & Medical Supplies Location: 5557 W 4100 S, West Valley City, Utah 84120 Phone: (801) 966-1118 |
Cvs Pharmacy #17590 Durable Medical Equipment & Medical Supplies Location: 5518 W High Market Dr, West Valley City, Utah 84120 Phone: (801) 449-8023 |
Wal Mart Pharmacy 10-5233 Durable Medical Equipment & Medical Supplies Location: 5675 West 6200 South, West Valley City, Utah 84118 Phone: (801) 965-0243 |
Harmons Pharmacy #01 Community/Retail Pharmacy Location: 3955 W 3500 S, West Valley City, Utah 84120 Phone: (801) 966-1497 |
Smiths Pharmacy #137 Durable Medical Equipment & Medical Supplies Location: 4643 S 4000 W, West Valley City, Utah 84120 Phone: (801) 968-1896 |
Otto Bock Orthopedic Services Llc Medicare Supplier Location: 2875 S Decker Lake Dr, West Valley City, Utah 84119 Phone: (801) 974-6650 |
Numotion Durable Medical Equipment & Medical Supplies Location: 2305 S Presidents Dr, West Valley City, Utah 84120 Phone: (385) 743-2325 |
Generational Health Llc Medicare Supplier Location: 1264 W Village Main Dr, West Valley City, Utah 84119 Phone: (801) 972-0393 |
News Archive
Moleac is pleased to announce the release of the CHIMES-E study results published online in the journal Cerebrovascular Diseases. It provides convincing data on NeuroAiD which confirm its persistent long-term benefits on patients' recovery after an ischemic stroke.
Efforts to standardize quality measures for medical tourism are underway as Mexico tries to attract medical tourists. Such efforts come after the swine flu outbreak significantly hurt Mexico's tourism industry, which ranks third as the country's source of foreign income.
A new Mayo Clinic study has found that Gamma Knifeā¢ stereotactic radiosurgery is a safe and effective option for selected children with arteriovenous malformations. This study was presented at the American Association of Neurological Surgeons Annual Meeting in Philadelphia last week.
Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that the first dose of vaccine has been administered thereby initiating the Company's phase I H1N1 influenza VLP vaccine candidate ("H1N1 vaccine") clinical trial in the United States. The primary safety and immunogenicity results for this trial are expected within three months.
Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.
› Verified 6 days ago